{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T02:50:07Z","timestamp":1767840607925,"version":"3.49.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,21]],"date-time":"2014-11-21T00:00:00Z","timestamp":1416528000000},"content-version":"vor","delay-in-days":20,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Letters"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.toxlet.2014.07.021","type":"journal-article","created":{"date-parts":[[2014,7,31]],"date-time":"2014-07-31T01:17:10Z","timestamp":1406769430000},"page":"467-478","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Detection of hepatotoxicity potential with metabolite profiling (metabolomics) of rat plasma"],"prefix":"10.1016","volume":"230","author":[{"given":"W.","family":"Mattes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Fabian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Greenhaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Herold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Looser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Mellert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Groeters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Marxfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Moeller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Montoya-Parra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Prokoudine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"van Ravenzwaay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Strauss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Walk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Kamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxlet.2014.07.021_bib0005","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1002\/hep.21424","article-title":"Outcome of acute idiosyncratic drug-induced liver injury: long-term follow-up in a hepatotoxicity registry","volume":"44","author":"Andrade","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.toxlet.2014.07.021_bib0010","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/00498250903046993","article-title":"Mechanism-based bioanalysis and biomarkers for hepatic chemical stress","volume":"39","author":"Antoine","year":"2009","journal-title":"Xenobiotica"},{"key":"10.1016\/j.toxlet.2014.07.021_bib0015","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.yrtph.2008.04.006","article-title":"Safety evaluation to support first-in-man investigations II: toxicology studies","volume":"51","author":"Baldrick","year":"2008","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.toxlet.2014.07.021_bib0020","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.taap.2009.11.019","article-title":"Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicity","volume":"243","author":"Beger","year":"2010","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.toxlet.2014.07.021_bib0025","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/toxsci\/kfs310","article-title":"Multiple NSAID-induced hits injure the small intestine: underlying mechanisms and novel strategies","volume":"131","author":"Boelsterli","year":"2013","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.toxlet.2014.07.021_bib0030","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1177\/0192623309332992","article-title":"Discovery of metabolomics biomarkers for early detection of nephrotoxicity","volume":"37","author":"Boudonck","year":"2009","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.toxlet.2014.07.021_bib0035","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3390\/ijms11010268","article-title":"Molecular mechanisms of microcystin toxicity in animal cells","volume":"11","author":"Campos","year":"2010","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.toxlet.2014.07.021_bib0040","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.drudis.2011.05.007","article-title":"FDA-approved drug labeling for the study of drug-induced liver injury","volume":"16","author":"Chen","year":"2011","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.toxlet.2014.07.021_bib0045","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/00313029209063634","article-title":"Concurrent zidovudine-induced myopathy and hepatoxicity in patients treated for human immunodeficiency virus (HIV) infection","volume":"24","author":"Chen","year":"1992","journal-title":"Pathology"},{"key":"10.1016\/j.toxlet.2014.07.021_bib0050","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2147\/DHPS.S24106","article-title":"Efficacy and safety of gonadotropin-releasing hormone agonists used in the treatment of prostate cancer","volume":"3","author":"Choi","year":"2011","journal-title":"Drug Healthc. Patient Saf."},{"key":"10.1016\/j.toxlet.2014.07.021_bib0055","doi-asserted-by":"crossref","first-page":"e9183","DOI":"10.1371\/journal.pone.0009183","article-title":"Nevirapine-associated early hepatotoxicity: incidence, risk factors, and associated mortality in a primary care ART programme in South Africa","volume":"5","author":"Chu","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.toxlet.2014.07.021_bib0060","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1177\/0192623307310947","article-title":"Metabolic profiling as a tool for understanding mechanisms of toxicity","volume":"36","author":"Clarke","year":"2008","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.toxlet.2014.07.021_bib0065","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/S0140-6736(05)66380-5","article-title":"Time and chance: the stochastic nature of disease causation","volume":"365","author":"Coggon","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.toxlet.2014.07.021_bib0070","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/BF03261997","article-title":"Current challenges and controversies in drug-induced liver injury","volume":"35","author":"Corsini","year":"2012","journal-title":"Drug Saf."},{"key":"10.1016\/j.toxlet.2014.07.021_bib0075","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1080\/01926230490268756","article-title":"Best practices guideline: toxicologic histopathology","volume":"32","author":"Crissman","year":"2004","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.toxlet.2014.07.021_bib0080","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2174\/157488408783329913","article-title":"AZT: an old drug with new perspectives","volume":"3","author":"D'Andrea","year":"2008","journal-title":"Curr. Clin. Pharmacol."},{"key":"10.1016\/j.toxlet.2014.07.021_bib0085","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.cbi.2003.08.003","article-title":"Protective effect of low molecular weight heparin on oxidative injury and cellular abnormalities in adriamycin-induced cardiac and hepatic toxicity","volume":"146","author":"Deepa","year":"2003","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.toxlet.2014.07.021_bib0090","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(03)13030-9","article-title":"Withdrawing drugs: nefazodone, the start of the latest saga","volume":"361","author":"Edwards","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.toxlet.2014.07.021_bib0095","doi-asserted-by":"crossref","first-page":"466","DOI":"10.7150\/ijbs.5.466","article-title":"Histopathological effects of cisplatin, doxorubicin and 5-flurouracil (5-FU) on the liver of male albino rats","volume":"5","author":"El-Sayyad","year":"2009","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.toxlet.2014.07.021_bib0100","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/toxsci\/kfq144","article-title":"Diagnostic performance of traditional hepatobiliary biomarkers of drug-induced liver injury in the rat","volume":"116","author":"Ennulat","year":"2010","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.toxlet.2014.07.021_bib0105","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1113\/jphysiol.1984.sp015126","article-title":"Increased or decreased thirst caused by inhibition of angiotensin-converting enzyme in the rat","volume":"348","author":"Evered","year":"1984","journal-title":"J. Physiol."},{"key":"10.1016\/j.toxlet.2014.07.021_bib0110","series-title":"Casarett and Doull\u2019s Toxicology","first-page":"107","article-title":"Risk assessment","author":"Faustman","year":"2008"},{"key":"10.1016\/j.toxlet.2014.07.021_bib0115","series-title":"Casarett and Doull\u2019s Toxicology: The Basic Science of Poisons","first-page":"45","article-title":"Mechanisms of toxicity","author":"Gregus","year":"2008"},{"key":"10.1016\/j.toxlet.2014.07.021_bib0120","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2165\/00002018-199106020-00004","article-title":"Drug-induced nephrotoxicity. Aetiology clinical features and management","volume":"6","author":"Hoitsma","year":"1991","journal-title":"Drug Saf."},{"key":"10.1016\/j.toxlet.2014.07.021_bib0125","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/hep.26175","article-title":"LiverTox: a website on drug-induced liver injury","volume":"57","author":"Hoofnagle","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.toxlet.2014.07.021_bib0130","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.yrtph.2013.02.002","article-title":"Target organ toxicities in studies conducted to support first time in man dosing: an analysis across species and therapy areas","volume":"65","author":"Horner","year":"2013","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.toxlet.2014.07.021_bib0135","first-page":"31","article-title":"Guidance on nonclinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals. vol. M3","author":"ICH Steering Committee","year":"2009","journal-title":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use"},{"key":"10.1016\/j.toxlet.2014.07.021_bib0140","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/toxsci\/65.2.166","article-title":"Mechanisms of hepatotoxicity","volume":"65","author":"Jaeschke","year":"2002","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.toxlet.2014.07.021_bib0145","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3109\/03602532.2011.602688","article-title":"Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicity","volume":"44","author":"Jaeschke","year":"2012","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.toxlet.2014.07.021_bib0150","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.4155\/bio.12.214","article-title":"Application of in vivo metabolomics to preclinical\/toxicological studies: case study on phenytoin-induced systemic toxicity","volume":"4","author":"Kamp","year":"2012","journal-title":"Bioanalysis"},{"key":"10.1016\/j.toxlet.2014.07.021_bib0155","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2165\/00002018-200730030-00005","article-title":"Drug-induced endocrine and metabolic disorders","volume":"30","author":"Ma","year":"2007","journal-title":"Drug Saf."},{"key":"10.1016\/j.toxlet.2014.07.021_bib0160","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1001\/archsurg.1976.01360250098021","article-title":"Neomycin toxicity revisited","volume":"111","author":"Masur","year":"1976","journal-title":"Arch. Surg."},{"key":"10.1016\/j.toxlet.2014.07.021_bib0165","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0306-3623(97)00006-2","article-title":"Actions of serotonergic agents on hypothalamic\u2013pituitary\u2013adrenal axis activity in the rat","volume":"29","author":"Matheson","year":"1997","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.toxlet.2014.07.021_bib0170","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1155\/2013\/202497","article-title":"Prediction of clinically relevant safety signals of nephrotoxicity through plasma metabolite profiling","volume":"2013","author":"Mattes","year":"2013","journal-title":"BioMed. Res. Int."},{"issue":"Suppl. 4","key":"10.1016\/j.toxlet.2014.07.021_bib0175","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1528-1157.44.s4.2.x","article-title":"Reproductive and metabolic disorders in women with epilepsy","volume":"44","author":"Morrell","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.toxlet.2014.07.021_bib0180","first-page":"366","article-title":"Renal and other lesions in dogs and rats from intramuscular injection of neomycin","volume":"10","author":"Nelson","year":"1951","journal-title":"Fed. Proc."},{"key":"10.1016\/j.toxlet.2014.07.021_bib0185","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1006\/taap.1996.0172","article-title":"In vivo toxicity of foscarnet and zidovudine given alone or in combination","volume":"139","author":"Omar","year":"1996","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.toxlet.2014.07.021_bib0190","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/01926230590522121","article-title":"Do preclinical testing strategies help predict human hepatotoxic potentials?","volume":"33","author":"Peters","year":"2005","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.toxlet.2014.07.021_bib0195","first-page":"399","article-title":"Captopril-associated agranulocytosis. A report of 3 cases","volume":"79","author":"Pillans","year":"1991","journal-title":"S Afr. Med. J."},{"key":"10.1016\/j.toxlet.2014.07.021_bib0200","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/ajh.2830400305","article-title":"Bleeding tendency, platelet function, and pharmacokinetics of ibuprofen and zidovudine in HIV(+) hemophilic men","volume":"40","author":"Ragni","year":"1992","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.toxlet.2014.07.021_bib0205","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/toxsci\/kfp056","article-title":"Standard and molecular NOAELs for rat testicular toxicity induced by flutamide","volume":"109","author":"Rouquie","year":"2009","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.toxlet.2014.07.021_bib0210","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.2174\/092986709788803097","article-title":"Current concepts of mechanisms in drug-induced hepatotoxicity","volume":"16","author":"Russmann","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.toxlet.2014.07.021_bib0215","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/lt.20204","article-title":"Liver transplantation for acute liver failure from drug induced liver injury in the United States","volume":"10","author":"Russo","year":"2004","journal-title":"Liver Transpl."},{"key":"10.1016\/j.toxlet.2014.07.021_bib0220","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/clpt.2008.262","article-title":"Monitoring for hepatotoxicity: what is the predictive value of liver function tests?","volume":"85","author":"Senior","year":"2009","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.toxlet.2014.07.021_bib0225","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/106002808902300102","article-title":"Phenytoin hepatotoxicity: a review of the literature","volume":"23","author":"Smythe","year":"1989","journal-title":"DICP"},{"key":"10.1016\/j.toxlet.2014.07.021_bib0230","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/070674370204700409","article-title":"Hepatic adverse reactions associated with nefazodone","volume":"47","author":"Stewart","year":"2002","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.toxlet.2014.07.021_bib0235","first-page":"799","article-title":"Prolonged zidovudine administration induces a moderate increase in the growth and steroidogenic capacity of the rat adrenal cortex","volume":"23","author":"Tortorella","year":"2009","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.toxlet.2014.07.021_bib0240","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0300-483X(95)03197-N","article-title":"Frequency and relationships of clinical chemistry and liver and kidney histopathology findings in 13-week toxicity studies in rats","volume":"107","author":"Travlos","year":"1996","journal-title":"Toxicology"},{"key":"10.1016\/j.toxlet.2014.07.021_bib0245","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1046\/j.1468-1293.2002.00105.x","article-title":"Body composition changes in protease inhibitor-naive HIV-infected patients treated with two nucleoside reverse transcriptase inhibitors","volume":"3","author":"Tsekes","year":"2002","journal-title":"HIV Med."},{"key":"10.1016\/j.toxlet.2014.07.021_bib0250","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nbt.1623","article-title":"Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies","volume":"28","author":"Vaidya","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.toxlet.2014.07.021_bib0255","series-title":"An Omics Perspective of Cancer","first-page":"141","article-title":"The use of metabolomics in cancer research","author":"van Ravenzwaay","year":"2010"},{"key":"10.1016\/j.toxlet.2014.07.021_bib0260","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.toxlet.2007.05.021","article-title":"The use of metabolomics for the discovery of new biomarkers of effect","volume":"172","author":"van Ravenzwaay","year":"2007","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.toxlet.2014.07.021_bib0265","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.mrgentox.2012.01.006","article-title":"Metabolomics: a tool for early detection of toxicological effects and an opportunity for biology based grouping of chemicals-from QSAR to QBAR","volume":"746","author":"van Ravenzwaay","year":"2012","journal-title":"Mutat. Res."},{"key":"10.1016\/j.toxlet.2014.07.021_bib0270","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s11306-009-0165-3","article-title":"Systems toxicology study of doxorubicin on rats using ultra performance liquid chromatography coupled with mass spectrometry based metabolomics","volume":"5","author":"Wang","year":"2009","journal-title":"Metabolomics"},{"key":"10.1016\/j.toxlet.2014.07.021_bib0275","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1006\/faat.1996.0022","article-title":"Harmonization of animal clinical pathology testing in toxicity and safety studies. The Joint Scientific Committee for International Harmonization of Clinical Pathology Testing","volume":"29","author":"Weingand","year":"1996","journal-title":"Fundam. Appl Toxicol"},{"key":"10.1016\/j.toxlet.2014.07.021_bib0280","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1634\/theoncologist.11-6-694","article-title":"Understanding and managing methotrexate nephrotoxicity","volume":"11","author":"Widemann","year":"2006","journal-title":"Oncologist"},{"key":"10.1016\/j.toxlet.2014.07.021_bib0285","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0022-5347(01)66596-0","article-title":"Flutamide hepatotoxicity","volume":"155","author":"Wysowski","year":"1996","journal-title":"J. Urol."},{"key":"10.1016\/j.toxlet.2014.07.021_bib0290","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.arcmed.2007.01.007","article-title":"Protective effects of erdosteine on doxorubicin-induced hepatotoxicity in rats","volume":"38","author":"Yagmurca","year":"2007","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.toxlet.2014.07.021_bib0295","series-title":"Hepatotoxicity: The Adverse Effects of Drugs and Other Chemicals on the Liver","first-page":"789","author":"Zimmerman","year":"1999"}],"container-title":["Toxicology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427414011874?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427414011874?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T11:20:40Z","timestamp":1565695240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378427414011874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0378427414011874"],"URL":"https:\/\/doi.org\/10.1016\/j.toxlet.2014.07.021","relation":{},"ISSN":["0378-4274"],"issn-type":[{"value":"0378-4274","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detection of hepatotoxicity potential with metabolite profiling (metabolomics) of rat plasma","name":"articletitle","label":"Article Title"},{"value":"Toxicology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxlet.2014.07.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}